Denali Therapeutics Correlations

DNLI Stock

USD 14.43 0.18 1.23%

The current 90-days correlation between Denali Therapeutics and Apellis Pharmaceuticals is 0.55 (i.e., Very weak diversification). The correlation of Denali Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Denali Therapeutics Correlation With Market

Weak diversification

The correlation between Denali Therapeutics and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.

Moving together with Denali Stock

0.71	CDIOW	Cardio Diagnostics	Pair Corr
0.7	SCLX	Scilex Holding	Pair Corr
0.67	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.66	CMND	Clearmind Medicine Common	Pair Corr
0.65	BA	Boeing	Pair Corr
0.78	CAT	Caterpillar	Pair Corr
0.87	HD	Home Depot	Pair Corr
0.76	DIS	Walt Disney	Pair Corr
0.82	MSFT	Microsoft	Pair Corr

Moving against Denali Stock

0.6	LUCD	Lucid Diagnostics	Pair Corr
0.46	WM	Waste Management	Pair Corr
0.39	PG	Procter Gamble	Pair Corr
0.7	JNJ	Johnson Johnson	Pair Corr
0.63	T	ATT Inc Earnings Call Today	Pair Corr
0.45	XOM	Exxon Mobil Corp	Pair Corr
0.39	CVX	Chevron Corp	Pair Corr
0.36	INTC	Intel	Pair Corr

Related Correlations Analysis

	FIXX	STOK	BCEL	BDTX	FDMT	ASND	APLS	BGNE	AKRO	BPMC
FIXX		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FIXX
STOK	0.0		0.0	0.77	0.84	-0.64	0.77	0.0	-0.13	0.38	STOK
BCEL	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	BCEL
BDTX	0.0	0.77	0.0		0.64	-0.69	0.62	0.0	0.0	0.69	BDTX
FDMT	0.0	0.84	0.0	0.64		-0.56	0.86	0.0	-0.28	0.16	FDMT
ASND	0.0	-0.64	0.0	-0.69	-0.56		-0.56	0.0	0.18	-0.67	ASND
APLS	0.0	0.77	0.0	0.62	0.86	-0.56		0.0	-0.54	0.15	APLS
BGNE	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	BGNE
AKRO	0.0	-0.13	0.0	0.0	-0.28	0.18	-0.54	0.0		0.18	AKRO
BPMC	0.0	0.38	0.0	0.69	0.16	-0.67	0.15	0.0	0.18		BPMC
	FIXX	STOK	BCEL	BDTX	FDMT	ASND	APLS	BGNE	AKRO	BPMC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

APLS	+ 0.86	FDMT
FDMT	+ 0.84	STOK
BDTX	+ 0.77	STOK
APLS	+ 0.77	STOK
BPMC	+ 0.69	BDTX
FDMT	+ 0.64	BDTX

High negative correlations

ASND	- 0.69	BDTX
BPMC	- 0.67	ASND
ASND	- 0.64	STOK
APLS	- 0.56	ASND
ASND	- 0.56	FDMT
AKRO	- 0.54	APLS

Risk-Adjusted Indicators

There is a big difference between Denali Stock performing well and Denali Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Denali Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
FIXX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
STOK	3.45	(0.39)	0.00	(0.32)	0.00	0.00	7.03	(9.08)	20.29
BCEL	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
BDTX	3.94	(0.29)	0.00	(0.21)	0.00	0.00	7.09	(7.35)	29.04
FDMT	4.02	(0.58)	0.00	(0.72)	0.00	0.00	7.08	(8.61)	25.91
ASND	2.49	0.49	0.19	0.38	2.24	(2.90)	5.86	(3.90)	18.15
APLS	2.14	(0.37)	0.00	(0.43)	0.00	0.00	4.11	(4.33)	20.77
BGNE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AKRO	4.30	1.28	0.36	0.70	2.89	(5.76)	4.92	(5.64)	104.81
BPMC	2.13	0.05	0.00	(0.03)	0.00	0.00	5.39	(4.23)	26.30

Denali Therapeutics Corporate Management

Peter Chin	Senior Affairs	Profile
Carole MD	Chief Development	Profile
Mark Rowen	Vice Development	Profile
Chris Walsh	General Counsel	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC